Picture of Cinclus Pharma Holding publ AB logo

CINPHA Cinclus Pharma Holding publ AB Cashflow Statement

0.000.00%
se flag iconLast trade - 00:00
HealthcareHighly SpeculativeMicro Cap

Annual cashflow statement for Cinclus Pharma Holding publ AB, fiscal year end - December 31st, SEK millions except per share, conversion factor applied.

2020
December 31st
2021
December 31st
2022
December 31st
2023
December 31st
2024
December 31st
Period Length:12 M12 M12 M12 M12 M
Source:PROSPECTUSPROSPECTUSPROSPECTUSPROSPECTUSARS
Standards:
IFRS
IFRS
IFRS
IFRS
IFRS
Status:FinalFinalFinalFinalFinal
Net Income/Starting Line-39.3-84.3-213-201-170
Depreciation
Non-Cash Items002.51-4.32-4.82
Other Non-Cash Items
Changes in Working Capital-0.1968.8516.9-5.15-5.25
Change in Accounts Receivable
Change in Accounts Payable
Change in Other Liabilities
Other Operating Cash Flow
Cash from Operating Activities-39.5-75.4-192-209-178
Capital Expenditures0-0.1310
Purchase of Fixed Assets
Other Investing Cash Flow Items-0.065000
Purchase of Investments
Other Investing Cash Flow
Cash from Investing Activities-0.065-0.13100
Financing Cash Flow Items-16.5-0.128-15.4-0.167-58.4
Other Financing Cash Flow
Net Issuance / Retirement of Stock
Net Issuance / Retirement of Debt
Cash from Financing Activities2334.95226123655
Foreign Exchange Effects
Beginning Cash Balance
Ending Cash Balance
Net Change in Cash195-70.335.3-85.6479